Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Constriction, Pathologic D003251 8 associated lipids
Thalassemia D013789 8 associated lipids
Arteriosclerosis Obliterans D001162 8 associated lipids
Thyroiditis, Autoimmune D013967 9 associated lipids
Leukopenia D007970 9 associated lipids
Salmonella Infections, Animal D012481 9 associated lipids
Immune Complex Diseases D007105 9 associated lipids
Staphylococcal Skin Infections D013207 9 associated lipids
Carbon Monoxide Poisoning D002249 9 associated lipids
Tachycardia, Ventricular D017180 9 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Fetal Growth Retardation D005317 9 associated lipids
Rhinitis D012220 10 associated lipids
Respiratory Syncytial Virus Infections D018357 10 associated lipids
Pancreatitis D010195 10 associated lipids
Central Nervous System Diseases D002493 10 associated lipids
Gastroesophageal Reflux D005764 10 associated lipids
Meningioma D008579 11 associated lipids
Pregnancy Complications, Hematologic D011250 11 associated lipids
Pregnancy Complications, Cardiovascular D011249 11 associated lipids
Shock, Septic D012772 11 associated lipids
Venous Thrombosis D020246 11 associated lipids
Uveitis, Anterior D014606 11 associated lipids
Infertility, Male D007248 11 associated lipids
Migraine Disorders D008881 11 associated lipids
Shock D012769 11 associated lipids
Death, Sudden D003645 12 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Blood Platelet Disorders D001791 12 associated lipids
Amnesia D000647 12 associated lipids
Hypertension, Portal D006975 12 associated lipids
Duodenal Ulcer D004381 12 associated lipids
Fetal Weight D020567 12 associated lipids
Polycythemia Vera D011087 13 associated lipids
Hypercalcemia D006934 13 associated lipids
Vitamin D Deficiency D014808 13 associated lipids
Multiple Sclerosis D009103 13 associated lipids
Heart Arrest D006323 13 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Stomatitis D013280 14 associated lipids
Angina, Unstable D000789 14 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Encephalitis D004660 15 associated lipids
Thrombocytopenia D013921 15 associated lipids
Hemorrhage D006470 15 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Neutropenia D009503 15 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Li SQ et al. Improving effect of Ginkgolide B on mitochondrial respiration of ischemic neuron after cerebral thrombosis in tree shrewa. 2007 Chin. Med. J. pmid:17908463
Doublier S et al. The proangiogenic phenotype of tumor-derived endothelial cells is reverted by the overexpression of platelet-activating factor acetylhydrolase. 2007 Clin. Cancer Res. pmid:17908960
Shimada T et al. Cross-regulation of cortisol secretion by adrenocorticotropin and platelet-activating factor in perfused guinea pig adrenals. 2007 J. Endocrinol. pmid:17911394
Whitehead SN et al. Identification and quantitation of changes in the platelet activating factor family of glycerophospholipids over the course of neuronal differentiation by high-performance liquid chromatography electrospray ionization tandem mass spectrometry. 2007 Anal. Chem. pmid:17949058
Bixby CE et al. Role of platelet-activating factor in pulmonary vascular remodeling associated with chronic high altitude hypoxia in ovine fetal lambs. 2007 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:17951313
Simonenko VB et al. [Comparative evaluation of the influence of sulfhydryl and phosphate ACE inhibitors on thrombocyte aggregation in patients suffering from atrerial hypertension with metabolic syndrome]. 2007 Klin Med (Mosk) pmid:17564032
Li Y et al. Autocrine activation of ion currents in the two-cell mouse embryo. 2007 Exp. Cell Res. pmid:17583695
Martin J et al. The dialogue between endothelial cells and monocytes/macrophages in vascular syndromes. 2007 Curr. Pharm. Des. pmid:17584105
Ferreira MA et al. Tumor growth, angiogenesis and inflammation in mice lacking receptors for platelet activating factor (PAF). 2007 Life Sci. pmid:17588613
Xia SH et al. Significance of platelet activating factor receptor expression in pancreatic tissues of rats with severe acute pancreatitis and effects of BN52021. 2007 World J. Gastroenterol. pmid:17589953
Tosaki T et al. Enhancement of acetyl-CoA: 1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine acetyltransferase activity by hydrogen peroxide. 2007 Biol. Pharm. Bull. pmid:17268064
Zhang X et al. Down-regulation of platelet-activating factor receptor gene expression during focal reversible cerebral ischemia in rats. 2007 Neurochem. Res. pmid:17268849
Sandford RM et al. The genetic basis of abdominal aortic aneurysms: a review. 2007 Eur J Vasc Endovasc Surg pmid:17276705
Zhao W et al. [Effect of PAF on the expression of PACAP mRNA in the granulosa cells of rat ovary]. 2007 Zhongguo Ying Yong Sheng Li Xue Za Zhi pmid:21180114
Viergutz T and Löhrke B Role of the platelet-activating factor and its receptor in the proliferative regulation of bovine ovarian granulosa cells. 2007 Cell Prolif. pmid:18021181
Chen Q et al. The yeast acylglycerol acyltransferase LCA1 is a key component of Lands cycle for phosphatidylcholine turnover. 2007 FEBS Lett. pmid:17996202
Ezoulin MJ et al. A new acetylcholinesterase inhibitor with anti-PAF activity modulates oxidative stress and pro-inflammatory mediators release in stimulated RAW 264.7 macrophage cells. Comparison with tacrine. 2007 Int. Immunopharmacol. pmid:17996678
Xavier RG et al. Enhanced platelet aggregation and activation under conditions of hypothermia. 2007 Thromb. Haemost. pmid:18064324
Dunkel B et al. Platelet activation in ponies with airway inflammation. 2007 Equine Vet. J. pmid:18065316
Lu SM et al. The phospholipid mediator platelet-activating factor mediates striatal synaptic facilitation. 2007 J Neuroimmune Pharmacol pmid:18040844
Li J et al. Pharmacological profile of PMS777, a new AChE inhibitor with PAF antagonistic activity. 2007 Int. J. Neuropsychopharmacol. pmid:16426477
Lo GK et al. What is the potential for overdiagnosis of heparin-induced thrombocytopenia? 2007 Am. J. Hematol. pmid:17722079
Chen J et al. Intracellular PAF catabolism by PAF acetylhydrolase counteracts continual PAF synthesis. 2007 J. Lipid Res. pmid:17693621
Shi W et al. [Study on composing mechanism by effect of disassembled compositions of Yiqi Huoxue decoction on platelet aggregation of health adults]. 2007 Zhongguo Zhong Yao Za Zhi pmid:18309677
Kuckleburg CJ et al. Expression of phosphorylcholine by Histophilus somni induces bovine platelet aggregation. 2007 Infect. Immun. pmid:17118985
Ibe BO et al. Platelet-activating factor modulates activity of cyclic nucleotides in fetal ovine pulmonary vascular smooth muscle. 2007 J. Pharmacol. Exp. Ther. pmid:17085546
Saluk-Juszczak J et al. The effect of lipopolysaccharide from Proteus mirabilis on the level of the stable end metabolic products of nitric oxide in blood platelets. 2007 Curr. Microbiol. pmid:17160361
Huang YH et al. Suppression effect of seminal vesicle autoantigen on platelet-activating factor-induced mouse sperm capacitation. 2007 J. Cell. Biochem. pmid:17131380
Osborn TM et al. Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolin. 2007 Am. J. Physiol., Cell Physiol. pmid:17135294
Eckert RE and Jones SL Regulation of VASP serine 157 phosphorylation in human neutrophils after stimulation by a chemoattractant. 2007 J. Leukoc. Biol. pmid:17684042
Subbotina LA [Procedure of blood agregation system analysis]. 2006 Sep-Oct Aviakosm Ekolog Med pmid:17357632
Givehchi A et al. Analysis of activity space by fragment fingerprints, 2D descriptors, and multitarget dependent transformation of 2D descriptors. 2006 May-Jun J Chem Inf Model pmid:16711727
Lang F et al. Osmotic shock-induced suicidal death of erythrocytes. 2006 May-Jun Acta Physiol (Oxf) pmid:16734755
Zhu T et al. Intracrine signaling through lipid mediators and their cognate nuclear G-protein-coupled receptors: a paradigm based on PGE2, PAF, and LPA1 receptors. 2006 Mar-Apr Can. J. Physiol. Pharmacol. pmid:16902584
Gu Y et al. PAF levels and PAF-AH activities in placentas from normal and preeclamptic pregnancies. 2006 Jun-Jul Placenta pmid:16122793
Lang F et al. Mechanisms and significance of eryptosis. 2006 Jul-Aug Antioxid. Redox Signal. pmid:16910766
Vasques E et al. Impairment of endothelium-dependent aorta relaxation by phospholipid components of oxidized low-density lipoprotein. 2006 Jan-Feb Endothelium pmid:16885061
Flamand N et al. Effects of pyrrophenone, an inhibitor of group IVA phospholipase A2, on eicosanoid and PAF biosynthesis in human neutrophils. 2006 Br. J. Pharmacol. pmid:16967052
Dianzani C et al. Evaluation of in-vitro anti-inflammatory activity of some 2-alkyl-4,6-dimethoxy-1,3,5-triazines. 2006 J. Pharm. Pharmacol. pmid:16451750
Gopichandran N and Leese HJ The effect of paracrine/autocrine interactions on the in vitro culture of bovine preimplantation embryos. 2006 Reproduction pmid:16452720
Fischer A et al. The ether lipid inositol-C2-PAF is a potent inhibitor of cell proliferation in HaCaT cells. 2006 Chembiochem pmid:16453359
Liu LR and Xia SH Role of platelet-activating factor in the pathogenesis of acute pancreatitis. 2006 World J. Gastroenterol. pmid:16489665
Fragopoulou E et al. Platelet-activating factor (PAF) increase intracellular lipid accumulation by increasing both LDL and scavenger receptors in human mesangial cells. 2006 J. Lab. Clin. Med. pmid:16750665
McLaughlin NJ et al. Platelet-activating factor-induced clathrin-mediated endocytosis requires beta-arrestin-1 recruitment and activation of the p38 MAPK signalosome at the plasma membrane for actin bundle formation. 2006 J. Immunol. pmid:16709866
Hsu HC et al. Alpha-bulnesene, a novel PAF receptor antagonist isolated from Pogostemon cablin. 2006 Biochem. Biophys. Res. Commun. pmid:16712790
Karagiorga G et al. Biochemical parameters of bronchoalveolar lavage fluid in fat embolism. 2006 Intensive Care Med pmid:16322975
Faghiri Z and Bazan NG Selective relocalization and proteasomal downregulation of PKCalpha induced by platelet-activating factor in retinal pigment epithelium. 2006 Invest. Ophthalmol. Vis. Sci. pmid:16384990
Pégorier S et al. Oxidized phospholipid: POVPC binds to platelet-activating-factor receptor on human macrophages. Implications in atherosclerosis. 2006 Atherosclerosis pmid:16386258
Karantonis HC et al. Effect of fast-food Mediterranean-type diet on type 2 diabetics and healthy human subjects' platelet aggregation. 2006 Diabetes Res. Clin. Pract. pmid:16236380
Wu J et al. Intestinal alkaline sphingomyelinase hydrolyses and inactivates platelet-activating factor by a phospholipase C activity. 2006 Biochem. J. pmid:16255717